CUPRIOR 150 mg, film-coated tablet 72 tablets
Active ingredients: TRIENTINE, Trientine tetrahydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet72 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CUPRIOR 150 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 9 plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 8 comprimé(s)
- Marketing authorisation holder
- ORPHALAN
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 May 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66671295CIP73015361CIP133400930153611Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRIENTINEcomprimé | 150 mg · un comprimé | FT |
| TÉTRACHLORHYDRATE DE TRIENTINEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.